Clinical Trials Logo

Candidiasis, Oral clinical trials

View clinical trials related to Candidiasis, Oral.

Filter by:

NCT ID: NCT00002399 Completed - HIV Infections Clinical Trials

A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the safety and effectiveness of SCH 56592 with that of fluconazole in the treatment of OPC (a fungal infection of the throat) in HIV-positive patients.

NCT ID: NCT00002394 Completed - HIV Infections Clinical Trials

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

Start date: n/a
Phase: N/A
Study type: Interventional

The purpose of this study is to see if it is safe and effective to give Lamisil to HIV-positive patients with thrush (a fungal infection) that has not responded to fluconazole.

NCT ID: NCT00002341 Completed - HIV Infections Clinical Trials

A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole

Start date: n/a
Phase: N/A
Study type: Interventional

To provide maintenance treatment with itraconazole solution for patients who were clinical responders in the ITR-USA-94 protocol, even if they subsequently relapsed.

NCT ID: NCT00002293 Completed - HIV Infections Clinical Trials

A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes

Start date: n/a
Phase: N/A
Study type: Interventional

To determine a safe, effective, and convenient dosing schedule for nystatin pastilles in the prophylaxis of oral candidiasis in patients with AIDS or AIDS related syndromes (group III or IV, CDC classification)

NCT ID: NCT00002282 Completed - HIV Infections Clinical Trials

A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS

Start date: n/a
Phase: N/A
Study type: Interventional

To compare the efficacy, safety, and tolerance of fluconazole single daily capsule for 14 days versus clotrimazole troche 5 x daily for 14 days in the treatment of oropharyngeal candidiasis in patients with AIDS.

NCT ID: NCT00002133 Completed - HIV Infections Clinical Trials

An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.

Start date: n/a
Phase: N/A
Study type: Interventional

To assess the efficacy and safety of itraconazole oral solution in HIV-seropositive patients with oropharyngeal candidiasis that is refractory to fluconazole.

NCT ID: NCT00002112 Completed - HIV Infections Clinical Trials

Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome

Start date: n/a
Phase: N/A
Study type: Interventional

To compare the efficacy, safety, and toleration of fluconazole as a single daily oral suspension for 14 days versus nystatin oral suspension 4 times daily for 14 days in the treatment of oropharyngeal candidiasis in patients with AIDS or HIV infection.

NCT ID: NCT00002057 Completed - HIV Infections Clinical Trials

Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC

Start date: n/a
Phase: N/A
Study type: Interventional

To determine a safe, effective, and convenient dosing schedule for nystatin pastilles in the prevention of oral candidiasis in patients with AIDS or AIDS related complex (ARC) (group III or IV, CDC classification).

NCT ID: NCT00001812 Completed - Clinical trials for Gastrointestinal Diseases

A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2

Start date: April 1999
Phase: Phase 3
Study type: Interventional

In patients who are receiving intravenous high dose Interleukin-2, patients will be randomized into two groups: group one will receive nystatin swish and swallow immediately before initiation of IL-2, and the second group will receive a placebo. The patients in each group will be monitored and evaluated for differences in the rate and severity of development of oral irritation during treatment. They will also be studied for differences between the two groups in the number of doses of IL-2 taken.

NCT ID: NCT00001542 Completed - Clinical trials for Acquired Immunodeficiency Syndrome

Fluconazole Prophylaxis of Thrush in AIDS

Start date: July 1996
Phase: Phase 4
Study type: Interventional

This is a placebo-controlled trial of intermittent fluconazole prophylaxis (200 mg orally three times a week) in the prevention of thrush.